drugset / Trial / NCT00845988
Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders
Phase 4
Completed
28 enrolled
Seoul National University Hospital
Korea Otsuka Pharmaceutical Co., Ltd. · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The primary goal of this study is to investigate metabolic changes and maintaining efficacy in stabilized patients with bipolar disorders who have pharmacologically induced weight gain.
Timeline
- Start
- 2008-12
- Primary completion
- 2012-03
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aripiprazole | Other / unclassified | 10 mg | Oral |